1
|
Bertarello A, Berruyer P, Artelsmair M, Elmore CS, Heydarkhan-Hagvall S, Schade M, Chiarparin E, Schantz S, Emsley L. In-Cell Quantification of Drugs by Magic-Angle Spinning Dynamic Nuclear Polarization NMR. J Am Chem Soc 2022; 144:6734-6741. [PMID: 35385274 PMCID: PMC9026252 DOI: 10.1021/jacs.1c12442] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The determination of intracellular drug concentrations can provide a better understanding of the drug function and efficacy. Ideally, this should be performed nondestructively, with no modification of either the drug or the target, and with the capability to detect low amounts of the molecule of interest, in many cases in the μM to nM range (pmol to fmol per million cells). Unfortunately, it is currently challenging to have an experimental technique that provides direct quantitative measurements of intracellular drug concentrations that simultaneously satisfies these requirements. Here, we show that magic-angle spinning dynamic nuclear polarization (MAS DNP) can be used to fulfill these requirements. We apply a quantitative 15N MAS DNP approach in combination with 15N labeling to quantify the intracellular amount of the drug [15N]CHIR-98014, an activator of the Wingless and Int-1 signaling pathway, determining intracellular drug amounts in the range of tens to hundreds of picomoles per million cells. This is, to our knowledge, the first time that MAS DNP has been used to successfully estimate intracellular drug amounts.
Collapse
Affiliation(s)
- Andrea Bertarello
- Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Pierrick Berruyer
- Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| | - Markus Artelsmair
- Early Chemical Development, Pharmaceutical Science, R&D, AstraZeneca, SE-431 83 Mölndal, Sweden
| | - Charles S Elmore
- Early Chemical Development, Pharmaceutical Science, R&D, AstraZeneca, SE-431 83 Mölndal, Sweden
| | - Sepideh Heydarkhan-Hagvall
- Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, SE-431 83 Mölndal, Sweden
| | - Markus Schade
- Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K
| | | | - Staffan Schantz
- Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, SE-431 83 Mölndal, Sweden
| | - Lyndon Emsley
- Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland
| |
Collapse
|
2
|
Faruqui N, Kummrow A, Fu B, Divieto C, Rojas F, Kisulu F, Cavalcante JJV, Wang J, Campbell J, Martins JL, Choi JH, Sassi MP, Zucco M, Vonsky M, Vessillier S, Zou S, Fujii SI, Ryadnov MG. Cellular Metrology: Scoping for a Value Proposition in Extra- and Intracellular Measurements. Front Bioeng Biotechnol 2020; 7:456. [PMID: 31993416 PMCID: PMC6970939 DOI: 10.3389/fbioe.2019.00456] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2019] [Accepted: 12/19/2019] [Indexed: 12/23/2022] Open
Abstract
The symptomatic irreproducibility of data in biomedicine and biotechnology prompts the need for higher order measurements of cells in their native and near-native environments. Such measurements may support the adoption of new technologies as well as the development of research programs across different sectors including healthcare and clinic, environmental control and national security. With an increasing demand for reliable cell-based products and services, cellular metrology is poised to help address current and emerging measurement challenges faced by end-users. However, metrological foundations in cell analysis remain sparse and significant advances are necessary to keep pace with the needs of modern medicine and industry. Herein we discuss a role of metrology in cell and cell-related R&D activities to underpin growing international measurement capabilities. Relevant measurands are outlined and the lack of reference methods and materials, particularly those based on functional cell responses in native environments, is highlighted. The status quo and current challenges in cellular measurements are discussed in the light of metrological traceability in cell analysis and applications (e.g., a functional cell count). An emphasis is made on the consistency of measurement results independent of the analytical platform used, high confidence in data quality vs. quantity, scale of measurements and issues of building infrastructure for end-users.
Collapse
Affiliation(s)
| | | | - Boqiang Fu
- National Institute of Metrology, Beijing, China
| | - Carla Divieto
- Istituto Nazionale di Ricerca Metrologica, Turin, Italy
| | - Fabiola Rojas
- Instituto de Salud Pública de Chile, Santiago, Chile
| | | | - Janaina J V Cavalcante
- National Institute of Metrology, Quality and Technology (INMETRO), Rio de Janeiro, Brazil
| | - Jing Wang
- National Institute of Metrology, Beijing, China
| | | | - Juliana L Martins
- National Institute of Metrology, Quality and Technology (INMETRO), Rio de Janeiro, Brazil
| | - Jun-Hyuk Choi
- Korea Research Institute of Standards and Science, Daejeon, South Korea
| | | | - Massimo Zucco
- Istituto Nazionale di Ricerca Metrologica, Turin, Italy
| | - Maxim Vonsky
- D. I. Mendeleyev Institute for Metrology, Saint Petersburg, Russia.,Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russia
| | - Sandrine Vessillier
- National Institute for Biological Standards and Control, Potters Bar, United Kingdom
| | - Shan Zou
- Metrology Research Centre, National Research Council, Ottawa, ON, Canada
| | | | | |
Collapse
|